Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lercanidipine HCl 20 mg vs ZANIDIP 20 mg in healthy Thai volunteers (fasting, pilot)
TCTR20260405009Phase 1Not yet recruiting
- Sponsor
- Dr. Sasitorn Kittivoravitkul
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lercanidipine (2 arms), sponsored by Dr. Sasitorn Kittivoravitkul. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
lercanidipine
Beyond the preview
Go deeper on TCTR20260405009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260405009.